Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Prostate Cancer
Related studies linked through entity extraction aliases.
Cyproterone Acetate in Treating Hot Flashes Following Surgical or Chemical Castration for Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Docetaxel in Treating Patients With Stage II or Stage III Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Ultrasound in Treating Patients With Recurrent Stage I or Stage II Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Zoledronate Plus Standard Therapy Compared With Placebo Plus Standard Therapy to Prevent Bone Metastases in Patients With Recurrent Prostate Cancer That Has No Symptoms
- Status
- TERMINATED
- Phase
- PHASE3
Leuvectin in Treating Patients With Locally Recurrent Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Estramustine and Paclitaxel in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy
- Status
- COMPLETED
- Phase
- PHASE1
Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Paclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Calcitriol and Zoledronate in Treating Patients With Progressive Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma
- Status
- TERMINATED
- Phase
- PHASE1
Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Arsenic Trioxide in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Previous Hormone Therapy
- Status
- COMPLETED
- Phase
- PHASE2
S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Mitoxantrone and Prednisone With or Without Leflunomide in Treating Patients With Stage IV Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE3